Literature DB >> 3009628

Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma.

R Cevenini, M Donati, U Caliceti, A Moroni, I Tamba, F Rumpianesi.   

Abstract

An association of Epstein-Barr virus (EBV) with nasopharyngeal carcinoma (NPC) has been established serologically in Italian patients. The finding of IgA antibodies to EBV-capsid antigen (VCA) and to early antigen (EA) showed a high degree of correlation for patients with NPC, thereby confirming previous reports. In addition, when considered together, IgA anti-VCA and IgG anti-EA antibody titres appeared to distinguish NPC-patients from those in control populations. Poorly differentiated and undifferentiated carcinomas with lymphoid cellular infiltrations showed the highest frequency of association with positive EBV serological tests.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3009628     DOI： 10.1016/s0163-4453(86)93558-9

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  3 in total

1.  Specific Epstein-Barr virus serological response in patients with nasopharyngeal carcinoma detected by immunoblotting.

Authors:  R Cevenini; M Donati; A Moroni; U Caliceti; A Rinaldi-Ceroni; M La Placa
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

2.  Short-term effect of different teaching methods on nasopharyngeal carcinoma for general practitioners in Jakarta, Indonesia.

Authors:  Maarten A Wildeman; Renske Fles; Marlinda Adham; Ika D Mayangsari; Ilse Luirink; Mara Sandberg; Andrew D Vincent; Faiziah Fardizza; Zanil Musa; Jaap M Middeldorp; Geerten Gerritsen; Ronny Suwanto; I Bing Tan
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

3.  Primary treatment results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia.

Authors:  Maarten A Wildeman; Renske Fles; Camelia Herdini; Rai S Indrasari; Andrew D Vincent; Maesadji Tjokronagoro; Sharon Stoker; Johan Kurnianda; Baris Karakullukcu; Kartika W Taroeno-Hariadi; Olga Hamming-Vrieze; Jaap M Middeldorp; Bambang Hariwiyanto; Sofia M Haryana; I Bing Tan
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.